O	0	4	Does
O	5	8	the
O	9	17	presence
O	18	20	of
O	21	23	an
B-Symptom	24	34	epiretinal
I-Symptom	35	43	membrane
O	44	49	alter
O	50	53	the
O	54	62	cleavage
O	63	68	plane
O	69	75	during
B-Anatomy	76	84	internal
I-Anatomy	85	93	limiting
I-Anatomy	94	102	membrane
O	103	110	peeling
O	110	111	?

O	113	115	To
O	116	125	determine
O	126	133	whether
O	134	137	the
O	138	146	presence
O	147	149	of
O	150	151	a
O	152	162	clinically
O	163	166	and
O	166	167	/
O	167	169	or
O	170	185	microscopically
O	186	196	detectable
B-Symptom	197	207	epiretinal
I-Symptom	208	216	membrane
O	217	218	(
B-Symptom	218	221	ERM
O	221	222	)
O	223	229	alters
O	230	233	the
O	234	242	cleavage
O	243	248	plane
O	249	255	during
B-Anatomy	256	264	internal
I-Anatomy	265	273	limiting
I-Anatomy	274	282	membrane
O	283	284	(
B-Anatomy	284	287	ILM
O	287	288	)
O	289	296	peeling
O	296	297	.

O	298	311	Retrospective
O	311	312	,
O	313	326	observational
O	326	327	,
O	328	347	immunohistochemical
O	348	353	study
O	354	356	of
B-Anatomy	357	360	ILM
O	361	370	specimens
O	371	376	using
O	377	385	archival
O	386	394	formalin
O	394	395	-
O	395	400	fixed
O	400	401	,
O	402	410	paraffin
O	410	411	-
O	411	419	embedded
O	420	426	tissue
O	426	427	.

O	428	433	Fifty
O	433	434	-
O	434	437	one
O	438	446	patients
O	447	450	who
O	451	454	had
O	455	458	had
B-Anatomy	459	462	ILM
O	463	471	excision
O	471	472	.

O	473	478	Fifty
O	478	479	-
O	479	482	one
B-Anatomy	483	486	ILM
O	487	496	specimens
O	497	503	peeled
O	504	510	during
O	511	521	vitrectomy
O	522	525	for
O	526	533	various
O	534	544	etiologies
O	545	549	were
O	550	558	examined
O	559	561	by
B-Diagnostic_tool	562	567	light
I-Diagnostic_tool	568	578	microscopy
O	578	579	.

O	580	583	The
O	584	591	removal
O	592	594	of
B-Anatomy	595	598	ILM
O	599	602	was
O	603	611	assisted
O	612	617	using
O	618	624	Trypan
O	625	629	blue
O	630	631	(
O	631	632	n
O	633	634	=
O	635	637	30
O	637	638	)
O	638	639	,
O	640	651	indocyanine
O	652	657	green
O	658	659	(
O	659	660	n
O	661	662	=
O	663	664	7
O	664	665	)
O	665	666	,
O	667	669	or
O	670	679	brilliant
O	680	684	blue
O	685	686	G
O	687	688	(
O	688	689	n
O	690	691	=
O	692	694	14
O	694	695	)
O	695	696	.

B-Characteristic	697	707	Monoclonal
I-Characteristic	708	718	antibodies
I-Characteristic	719	721	to
I-Characteristic	722	727	glial
I-Characteristic	728	738	fibrillary
I-Characteristic	739	745	acidic
I-Characteristic	746	753	protein
I-Characteristic	754	757	and
I-Characteristic	758	760	to
I-Characteristic	761	774	neurofilament
I-Characteristic	775	782	protein
O	783	787	were
O	788	792	used
O	793	795	to
O	796	802	detect
B-Anatomy	803	808	glial
I-Anatomy	809	811	or
I-Anatomy	812	820	neuronal
I-Anatomy	821	826	cells
O	827	839	respectively
O	840	842	on
O	843	846	the
B-Anatomy	847	855	vitreous
I-Anatomy	856	858	or
I-Anatomy	859	866	retinal
I-Anatomy	867	875	surfaces
I-Anatomy	876	878	of
I-Anatomy	879	882	the
I-Anatomy	883	886	ILM
O	886	887	.

O	888	897	Specimens
O	898	902	were
O	903	910	divided
O	911	915	into
O	916	917	2
O	918	924	groups
O	924	925	:
B-Anatomy	926	929	ILM
O	930	936	peeled
O	937	940	for
B-Characteristic	941	945	full
I-Characteristic	945	946	-
I-Characteristic	946	955	thickness
I-Characteristic	956	963	macular
I-Characteristic	964	968	hole
O	969	970	(
B-Characteristic	970	972	MH
O	972	973	;
O	974	975	n
O	976	977	=
O	978	980	31
O	980	981	)
O	982	985	and
B-Anatomy	986	989	ILM
O	990	996	peeled
O	997	1002	after
O	1003	1010	removal
O	1011	1013	of
O	1014	1024	clinically
O	1025	1035	detectable
B-Symptom	1036	1039	ERM
O	1040	1041	(
O	1041	1042	n
O	1043	1044	=
O	1045	1047	20
O	1047	1048	)
O	1048	1049	.

O	1050	1057	Primary
O	1058	1065	outcome
O	1066	1073	measure
O	1074	1077	was
O	1078	1081	the
O	1082	1094	localization
O	1095	1097	of
B-Characteristic	1098	1117	immunohistochemical
I-Characteristic	1118	1125	markers
O	1126	1128	to
B-Anatomy	1129	1137	neuronal
I-Anatomy	1138	1140	or
I-Anatomy	1141	1146	glial
I-Anatomy	1147	1152	cells
I-Anatomy	1153	1155	on
I-Anatomy	1156	1159	the
I-Anatomy	1160	1168	vitreous
I-Anatomy	1169	1171	or
I-Anatomy	1172	1179	retinal
I-Anatomy	1180	1188	surfaces
I-Anatomy	1189	1191	of
I-Anatomy	1192	1195	ILM
O	1195	1196	.

O	1197	1200	The
O	1201	1210	secondary
O	1211	1218	outcome
O	1219	1226	measure
O	1227	1230	was
O	1231	1234	the
O	1235	1246	correlation
O	1247	1249	of
O	1250	1253	the
O	1254	1261	results
O	1262	1264	of
O	1265	1268	the
O	1269	1276	primary
O	1277	1284	measure
O	1285	1289	with
O	1290	1293	the
O	1294	1298	dyes
O	1299	1303	used
O	1304	1306	to
O	1307	1317	facilitate
B-Anatomy	1318	1321	ILM
O	1322	1329	peeling
O	1329	1330	.

B-Anatomy	1331	1336	Glial
I-Anatomy	1337	1340	and
I-Anatomy	1340	1341	/
I-Anatomy	1341	1343	or
I-Anatomy	1344	1352	neuronal
I-Anatomy	1353	1358	cells
O	1359	1363	were
O	1364	1372	detected
O	1373	1375	on
O	1376	1379	the
B-Anatomy	1380	1387	retinal
I-Anatomy	1388	1395	surface
O	1396	1398	of
O	1399	1402	the
B-Anatomy	1403	1406	ILM
O	1407	1409	in
O	1410	1412	10
O	1413	1415	of
O	1416	1418	31
O	1419	1420	(
O	1420	1422	32
O	1422	1423	%
O	1423	1424	)
O	1425	1427	of
O	1428	1431	the
B-Characteristic	1432	1434	MH
I-Characteristic	1435	1438	ILM
O	1439	1448	specimens
O	1449	1452	and
O	1453	1455	in
O	1456	1458	13
O	1459	1461	of
O	1462	1464	20
O	1465	1466	(
O	1466	1468	65
O	1468	1469	%
O	1469	1470	)
O	1471	1473	of
O	1474	1477	the
B-Anatomy	1478	1481	ILM
O	1482	1488	peeled
O	1489	1494	after
B-Symptom	1495	1498	ERM
O	1499	1507	excision
O	1507	1508	;
O	1509	1512	the
O	1513	1523	difference
O	1524	1527	was
O	1528	1539	significant
O	1540	1541	(
O	1541	1542	P
O	1543	1544	=
O	1545	1546	0
O	1546	1547	.
O	1547	1549	02
O	1549	1550	)
O	1550	1551	.

O	1552	1557	There
O	1558	1561	was
O	1562	1564	no
O	1565	1576	association
O	1577	1584	between
O	1585	1588	the
O	1589	1597	presence
O	1598	1600	of
B-Anatomy	1601	1609	neuronal
I-Anatomy	1610	1613	and
I-Anatomy	1614	1619	glial
I-Anatomy	1620	1625	cells
O	1626	1630	with
O	1631	1634	the
O	1635	1639	type
O	1640	1642	of
O	1643	1646	dye
O	1647	1651	used
O	1652	1653	(
O	1653	1654	P
O	1655	1656	=
O	1657	1658	0
O	1658	1659	.
O	1659	1660	2
O	1660	1661	)
O	1661	1662	.

O	1663	1665	Of
O	1666	1669	the
O	1670	1672	23
B-Anatomy	1673	1676	ILM
O	1677	1686	specimens
O	1687	1691	with
O	1692	1697	cells
O	1698	1706	attached
O	1707	1709	to
O	1710	1713	the
B-Anatomy	1714	1721	retinal
I-Anatomy	1722	1729	surface
O	1729	1730	,
O	1731	1733	21
O	1734	1735	(
O	1735	1737	91
O	1737	1738	%
O	1738	1739	)
O	1740	1744	were
O	1745	1755	associated
O	1756	1760	with
O	1761	1769	clinical
O	1770	1773	and
O	1773	1774	/
O	1774	1776	or
O	1777	1787	histologic
O	1788	1796	evidence
O	1797	1799	of
B-Symptom	1800	1803	ERM
O	1804	1807	and
O	1808	1809	2
O	1810	1811	(
O	1811	1812	9
O	1812	1813	%
O	1813	1814	)
O	1815	1819	were
O	1820	1823	not
O	1823	1824	.

O	1825	1828	The
O	1829	1840	correlation
O	1841	1848	between
O	1849	1852	the
O	1853	1861	presence
O	1862	1864	of
B-Anatomy	1865	1870	cells
I-Anatomy	1871	1873	on
I-Anatomy	1874	1877	the
I-Anatomy	1878	1886	vitreous
I-Anatomy	1887	1890	and
I-Anatomy	1891	1894	the
I-Anatomy	1895	1902	retinal
I-Anatomy	1903	1911	surfaces
I-Anatomy	1912	1914	of
I-Anatomy	1915	1918	ILM
O	1919	1922	was
O	1923	1927	high
O	1928	1929	(
O	1929	1930	P
O	1931	1932	<
O	1933	1934	0
O	1934	1935	.
O	1935	1939	0001
O	1939	1940	)
O	1940	1941	.

O	1942	1945	The
O	1946	1954	findings
O	1955	1962	suggest
O	1963	1967	that
B-Symptom	1968	1971	ERM
O	1972	1975	may
O	1976	1978	be
O	1979	1989	associated
O	1990	1994	with
B-Characteristic	1995	1998	sub
I-Characteristic	1998	1999	-
I-Characteristic	1999	2002	ILM
I-Characteristic	2003	2010	changes
O	2011	2015	that
O	2016	2021	alter
O	2022	2025	the
O	2026	2031	plane
O	2032	2034	of
O	2035	2045	separation
O	2046	2052	during
B-Anatomy	2053	2056	ILM
O	2057	2064	peeling
O	2064	2065	.

O	2066	2070	This
O	2071	2076	study
O	2077	2081	does
O	2082	2085	not
O	2086	2093	confirm
O	2094	2097	any
O	2098	2107	influence
O	2108	2110	of
O	2111	2115	dyes
O	2116	2118	on
O	2119	2122	the
O	2123	2131	cleavage
O	2132	2137	plane
O	2138	2144	during
O	2145	2152	surgery
O	2152	2153	.
